What is Xigris used for?
Xigris drotrecogin alfa (activated)
EPAR summary for the public
This document is a summary of the European Public Assessment Report authorised(EPAR). It explains how
the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach their recommendations on how to use the medicine.
If you need more information about your medical condition or your treatment, read the Package Leaflet (also part of the EPAR) or contact your doctor or pharmacist. If you want more information on the basis for the CHMP recommendations, read the Scientific Discussion (also part of the EPAR).
Xigris is a powder that is made up into a solution for infusion (drip into a vein). It contains the active substance drotrecogin alfa (activated).
addition to best standard care such as antibiotics,nomedicines to support the organs and treatment in a specialised unit. Xigris should be used mainly when it can be started within 24 hours of the organ failure. It is intended for
Xigris is used in adult patients with severe sepsis. Sepsis is a condition when bacteria get into the
bloodstream and produce harmful substances (toxins). The toxins cause the patient’s organs to fail,